Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
2.310
0.00 (0.00%)
At close: Jun 27, 2025, 4:00 PM
2.320
+0.010 (0.43%)
After-hours: Jun 27, 2025, 5:48 PM EDT
Autolus Therapeutics Employees
As of December 31, 2024, Autolus Therapeutics had 650 total employees, including 647 full-time and 3 part-time employees. The number of employees increased by 179 or 38.00% compared to the previous year.
Employees
650
Change (1Y)
179
Growth (1Y)
38.00%
Revenue / Employee
$13,863
Profits / Employee
-$366,358
Market Cap
616.12M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
AUTL News
- 15 days ago - Autolus Therapeutics Presents Long-Term Follow Up from the FELIX Study Demonstrating Obe-Cel's Potential for Long-Term Remission in R/R B-ALL at the 2025 European Hematology Association (EHA) Congress - GlobeNewsWire
- 21 days ago - Autolus: A Buy Before Key Data Readout, Potential Expansion Into Autoimmune Market - Seeking Alpha
- 4 weeks ago - Autolus Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 5 weeks ago - Autolus Therapeutics Announces Positive CHMP Opinion for Obecabtagene Autoleucel for Adult Patients (age 26 and older) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL) - GlobeNewsWire
- 5 weeks ago - I Missed The Quantum Rally - I Won't Miss The Next One - Seeking Alpha
- 6 weeks ago - Autolus Therapeutics Presents Clinical Data Updates at the 2025 European Hematology Association (EHA) Congress - GlobeNewsWire
- 6 weeks ago - Autolus Therapeutics plc (AUTL) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Autolus Therapeutics Reports First Quarter 2025 Financial Results and Business Updates - GlobeNewsWire